小儿呼吸机相关性肺炎中鲍曼不动杆菌的研究进展  

Progress in research on Acinetobacter baumannii in pediatric ventilator-associated pneumonia

作　　者：娄永峥 吴军华[2] 邱海燕[2] LOU Yong-zheng;WU Jun-hua;QIU Hai-yan(Ningbo Universily,Ningbo,Zhejiang 315211,China)

机构地区：[1]宁波大学,浙江宁波315211 [2]宁波市妇女儿童医院

出　　处：《中国微生态学杂志》2021年第4期482-486,共5页Chinese Journal of Microecology

基　　金：浙江省医药卫生项目(2016RCB017)。

摘　　要：随着呼吸机在危重患儿中的应用,越来越多的儿童从中受益,而呼吸机相关性肺炎作为其并发症引起了医疗工作者的关注。鲍曼不动杆菌是引起该并发症常见的病原体,重症监护病房中患儿感染该病原体的机会更多。由于鲍曼不动杆菌存在多种耐药机制,致使多种抗生素对其治疗效果不佳,进而使临床工作中对该病原体感染的治疗难度增加。本文主要是对近年来小儿呼吸机相关性肺炎鲍曼不动杆菌的定植情况、分布情况、相关危险因素及耐药现状的研究进展进行综述。With the application of ventilator in critically ill children, more and more children benefit from it, and ventilator-associated pneumonia, as a complication, has attracted the attention of medical workers. Acinetobacter baumannii is a common pathogen causing this complication, and children in intensive care units are more likely to be infected with this pathogen. Because Acinetobacter baumannii has multiple drug resistance mechanisms, many antibiotics have poor therapeutic effect on Acinetobacter baumannii, which makes the treatment of the pathogen infection more difficult in clinical practice. This paper is mainly to review the progress in research on the colonization, distribution, related risk factors and drug resistance of Acinetobacter baumannii in children with ventilator-associated pneumonia in recent years.

关 键 词：呼吸机相关性肺炎 儿童 鲍曼不动杆菌 耐药现状 

分 类 号：R725.6[医药卫生—儿科]